Article
TRPM2: a candidate therapeutic target for treating neurological diseases.
Acta pharmacologica Sinica - 1 May 2018
Belrose Jillian Corinne, Jackson Michael Frederick
Abstract excerpt
Transient receptor potential melastatin 2 (TRPM2) is a calcium (Ca2+)-permeable non-selective cation channel belonging to the TRP ion channel family. Oxidative stress-induced TRPM2 activation provokes aberrant intracellular Ca2+ accumulation and cell death in a variety of cell types, including neurons. Aberrant TRPM2 function has been implicated in several neurological disorders including ischemia/stroke,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
